A higher blood glucose level pre-breakfast in comparison to bedtime is a contraindication for intensification of prandial insulin therapy in patients with type 2 diabetes – The impact of a negative BeAM value-Reference-Cited by-同舟云学术

A higher blood glucose level pre-breakfast in comparison to bedtime is a contraindication for intensification of prandial insulin therapy in patients with type 2 diabetes – The impact of a negative BeAM value

Published:2018-12 Issue: Volume:14 Page:34-38
ISSN:2214-6237
Container-title:Journal of Clinical & Translational Endocrinology
language:en
Short-container-title:Journal of Clinical & Translational Endocrinology

Author:

Siegmund Thorsten,Borck Anja,Zisman Ariel,Bramlage Peter,Kress Stephan

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference23 articles.

1. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes. 1995; 44, pp. 1249–1258.

2. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;Jama,1999

3. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

4. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus;Bonora;Diabetologia,2006

5. When basal insulin therapy in type 2 diabetes mellitus is not enough–what next?;Raccah;Diab/Metab Res Rev,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2021-03

2. Wann mit der intensivierten Insulintherapie beginnen? – Der BeAM-Wert zur besseren Abschätzung einer prandialen Insulintherapie bei Typ-2-Diabetes mellitus;Diabetologie und Stoffwechsel;2019-07-12